国产美女网I在线成人免费I日韩在线免费播放I蜜臀一区二区三区精品免费视频Ia视频在线I偷拍福利视频一区二区三区I免费成人在线观看

Recently, C&D Emerging Industry Equity Investment has received several industry awards. It was ranked NO. 3 on the “2025 Top 100 Industrial Investors” list released by FOF Weekly, and was named one of the “Top 50 Best Corporate Venture Investors in China for 2024” by CVINFO. In addition, several of its portfolio companies—including Impact Therapeutics, Pins Medical, Aidite, Narwal Robotics, SJ SEMI, Kaida Hengye, and AMiner—also received multiple awards on the CVINFO list. In addition, in the “2024 China Best Institutional LP List” released by Chulei Research Institute, C&D Emerging Industry Equity Investment was recognized as one of the “Top 20 Best Institutional LPs in China for 2024” and “Top 10 Best Direct Investment LPs in China for 2024.”

C&D Emerging Industry Equity Investment will remain committed to the mission of "exploring new values for more emerging enterprises to achieve better development", continue to provide unwavering assistance to exceptional fund managers and entrepreneurs, actively promote industrial upgrading and structural optimization, and inject momentum into the development of emerging industries.